AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nuvation Bio Inc. Director's Dealing 2024

Jan 10, 2024

32154_dirs_2024-01-10_68d4f765-1c58-46da-b115-c4d180472793.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2024-01-08

Reporting Person: Mashal Robert (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-08	Stock Option (Right to Buy)	$1.55	A	741179	Acquired	2034-01-07	Class A Common Stock (741179)	Direct

Footnotes

F1: 1/36th of the total number of shares shall vest and become exercisable on each monthly anniversary of January 8, 2024, subject to Reporting Person's continuous service on each such vesting date.